1019927-13-9

Basic information

• Product Name: 1-oxy-4-phenyl-pyridine-2-carbonitrile
• Synonyms: 1-oxy-4-phenyl-pyridine-2-carbonitrile
• CAS NO: 1019927-13-9
• Molecular Weight: 196.208
• Mol File: 1019927-13-9.mol

Chemical Properties

• CAS DataBase Reference: 1-oxy-4-phenyl-pyridine-2-carbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 1-oxy-4-phenyl-pyridine-2-carbonitrile(1019927-13-9)
• EPA Substance Registry System: 1-oxy-4-phenyl-pyridine-2-carbonitrile(1019927-13-9)

Safety Data

• Hazardous Substances Data: 1019927-13-9(Hazardous Substances Data)

Upstream product

• 1131-61-9 4-Phenylpyridine 1-oxide 
• 7677-24-9 trimethylsilyl cyanide 
• 18714-16-4 4-phenyl-pyridine-2-carbonitrile 

Downstream Products

• 106719-06-6 6-chloro-4-phenyl-pyridine-2-carbonitrile 
• 1191264-04-6 4-[(R)-2-[(6-chloro-4-phenyl-pyridine-2-carbonyl)-amino]-3-(diethoxy-phosphoryl)-propionyl]-piperazine-1-carboxylic acid butyl ester 
• 1191264-06-8 4-((R)-3-(diethoxy-phosphoryl)-2-{[6-(2-fluoro-phenyl)-4-phenyl-pyridine-2-carbonyl]-amino}-propionyl)-piperazine-1-carboxylic acid butyl ester 
• 52565-56-7 4-phenylpyridine-2-carboxylic acid 

Relevant articles and documents

SUBSTITUTED 2-PHENYL-PYRIDINE DERIVATIVES

The present invention relates to compounds of formula I wherein R1, R2, R4, R5, Ra, Rb, n, W and Z are as defined in the application, their preparation and their use as P2Y12 receptor antagonists in the treatment and/or prevention of peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular and of cerebrovascular diseases or conditions associated with platelet aggregation, including thrombosis in humans and other mammals.

SUBSTITUTED 2-PHENYL-PYRIDINE DERIVATIVES

The present invention relates to compounds of formula (I) wherein R1, R2, R4, R5, Ra, Rb, n, W and Z are as defined in the application, their preparation and their use as P2Y12 receptor antagonists in the treatment and/or prevention of peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular and of cerebrovascular diseases or conditions associated with platelet aggregation, including thrombosis in humans and other mammals.

2-AMINOCARBONYL-PYRIDINE DERIVATIVES

The present invention relates to 2-aminocarbonyl-pyridine derivatives and their use as P2Yi2 receptor antagonists in the treatment and/or prevention of peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular and of cerebrovascular diseases or conditions associated with platelet aggregation, including thrombosis in humans and other mammals.

LINCOMYCIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY

Novel lincomycin derivatives are disclosed. These lincomycin derivatives exhibit antibacterial activity. As the compounds of the subject invention exhibit potent activities against bacteria, including gram positive organisms, they are useful antimicrobial agents. Methods of synthesis and of use of the compounds are also disclosed.